Recombinant lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice.

CONCLUSIONS: Recombinant L. lactis expressing VP1 of EV71 has the potential to be used as an oral vaccine candidate. The findings may provide some preliminary evidences for further development of effective and needle-free EV71 vaccines.
PMID: 31119429 [PubMed - as supplied by publisher]

Source: Biotechnology Letters - May 21, 2019 Category: Biotechnology Authors: Xu P, Wang Y, Tao L, Wu X, Wu W Tags: Biotechnol Lett Source Type: research